These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

29 related articles for article (PubMed ID: 29469171)

  • 1. Auditing ultrasound assessment of fetal nuchal translucency thickness: a review of Australian National Data 2002-2008.
    Nisbet DL; Robertson AC; Schluter PJ; McLennan AC; Hyett JA
    Aust N Z J Obstet Gynaecol; 2010 Oct; 50(5):450-5. PubMed ID: 21039379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maintaining quality assurance for sonographic nuchal translucency measurement: lessons from the FASTER Trial.
    D'Alton ME; Cleary-Goldman J; Lambert-Messerlian G; Ball RH; Nyberg DA; Comstock CH; Bukowski R; Berkowitz RL; Dar P; Dugoff L; Craigo SD; Timor IE; Carr SR; Wolfe HM; Dukes K; Canick JA; Malone FD
    Ultrasound Obstet Gynecol; 2009 Feb; 33(2):142-6. PubMed ID: 19173241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of nuchal translucency credentialing by the FMF, the NTQR or both on screening distributions and performance.
    Evans MI; Krantz DA; Hallahan TW; Sherwin J
    Ultrasound Obstet Gynecol; 2012 Feb; 39(2):181-4. PubMed ID: 21484907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality management of nuchal translucency ultrasound measurement in Australia.
    Nisbet D; Robertson A; Mannil B; Pincham V; Mclennan A
    Aust N Z J Obstet Gynaecol; 2019 Feb; 59(1):54-58. PubMed ID: 29469171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuchal translucency and first trimester risk assessment: a systematic review.
    Sheppard C; Platt LD
    Ultrasound Q; 2007 Jun; 23(2):107-16. PubMed ID: 17538486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuchal translucency-based Down syndrome screening: barriers to implementation.
    Malone FD
    Semin Perinatol; 2005 Aug; 29(4):272-6. PubMed ID: 16104681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Down syndrome screening by ultrasound].
    Rozenberg P
    Gynecol Obstet Fertil; 2005; 33(7-8):526-32. PubMed ID: 16005667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality Requirements for the early Fetal Ultrasound Assessment at 11-13+6 Weeks of Gestation (DEGUM Levels II and III).
    von Kaisenberg C; Chaoui R; Häusler M; Kagan KO; Kozlowski P; Merz E; Rempen A; Steiner H; Tercanli S; Wisser J; Heling KS
    Ultraschall Med; 2016 Jun; 37(3):297-302. PubMed ID: 27093520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and management of fetal nuchal translucency.
    Jackson M; Rose NC
    Semin Roentgenol; 1998 Oct; 33(4):333-8. PubMed ID: 9800243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fetal nuchal translucency].
    Nicolaides KH; Wegrzyn P
    Ginekol Pol; 2005 Mar; 76(3):179-86. PubMed ID: 16018135
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.